News

ASX
LCT 0.033   Last updated 12.43 pm
Fact sheet
The following fact sheets provide a summary of our current business and research pipeline.
Register for email updates
Register now to receive our newsletter and updates on LCT’s activities and progress.

Fact sheet

The following fact sheet provides a summary of our current business and research pipeline.

save-icon

Investor call: NTCELL Phase IIb study findings

Listen to CEO Dr Ken Taylor and Principal Invesigator Dr Barry Snow discuss the top-line results of the Phase IIb study of NTCELL in Parkinson's disease.

— 10 November 2017

save-icon

Halting Parkinson's with cell therapy

Presentation from Dr Ken Taylor to NZBIO summer reception

— 28 February 2017

save-icon

Chairman's and CEO's presentations to the AGM

Mr Roy Austin's and Dr Ken Taylor's presentations at the LCT AGM on 16 November 2016.

— 16 November 2016

Load More
Register for email updates
Register now to receive our newsletter and updates on LCT’s activities and progress.